CRA engagements win in 2024 GCR Awards
The high-profile acquisition of Activision by Microsoft, which CRA Competition’s teams advised on was named overall Matter of the Year, as well as Matter of...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Dr. Deng is an expert on antitrust and intellectual property analysis in China. She has testified in a number of Chinese courts, including the Beijing, Shanghai, and Shenzhen IP courts and the Guangdong High Court in cases involving allegations of abuse of dominance and in standard essential patent (SEP) disputes involving FRAND rate setting and injunctions.
Having been one of the first outside economic experts engaged by China’s antitrust agency, she has extensive experience working with the agency on both sides of the table in merger reviews and antitrust investigation matters. Dr. Deng’s work spans many industries, including digital platforms, telecommunications, and various consumer and industrial goods and services.
She is currently an editor of the American Bar Association (ABA) publication Antitrust. She has published extensively both in English and in Chinese, in journals such as American Law and Economics Review, Antitrust Law Journal, Antitrust, The Antitrust Source, Law360, CPI Antitrust Chronicle, Intellectual Asset Management Magazine, Caixin.com, and chapters in books such as Issues in Competition Law and Policy, China’s Anti-Monopoly Law – The First Five Years, and Economic Approaches to Intellectual Property – Policy, Litigation and Management.
Global Competition Review has recognized Dr. Deng as “highly regarded, with sought-after expertise on advising Chinese companies on US antitrust law, and vice versa.”